Agilent Technologies (A) Current Deferred Revenue (2009 - 2026)
Agilent Technologies (A) posted quarterly Current Deferred Revenue of $665.0 million for Q2 2026, up 5.89% year-over-year from $628.0 million in Q2 2025, and down 2.49% sequentially from $682.0 million in Q1 2026.
Agilent Technologies (A) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Agilent Technologies has disclosed Current Deferred Revenue across 18 years of filings, most recently posting $665.0 million for Q2 2026.
- For the quarter ending Q2 2026, Current Deferred Revenue rose 5.89% year-over-year to $665.0 million; the trailing twelve-month figure through Apr 2026 stood at $665.0 million (up 5.89% YoY), and the FY2025 full-year result was $624.0 million, up 14.71% from the prior year.
- Current Deferred Revenue was $665.0 million for Q2 2026 at Agilent Technologies, down from $682.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $682.0 million in Q1 2026 and troughed at $461.0 million in Q4 2022.
- The 5-year median for Current Deferred Revenue is $523.0 million (2024), against an average of $554.1 million.
- Year-over-year, Current Deferred Revenue advanced 19.11% in 2022 and advanced 0.19% in 2024.
- Year by year, Current Deferred Revenue stood at $461.0 million in 2022, then rose by 9.54% to $505.0 million in 2023, then rose by 7.72% to $544.0 million in 2024, then climbed by 14.71% to $624.0 million in 2025, then gained by 6.57% to $665.0 million in 2026.
- Per Business Quant, the three latest A Current Deferred Revenue figures stand at $665.0 million (Q2 2026), $682.0 million (Q1 2026), and $624.0 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 665.00 Mn |
| Jan 31, 2026 | 682.00 Mn |
| Oct 31, 2025 | 624.00 Mn |
| Jul 31, 2025 | 620.00 Mn |
| Apr 30, 2025 | 628.00 Mn |
| Jan 31, 2025 | 612.00 Mn |
| Oct 31, 2024 | 544.00 Mn |
| Jul 31, 2024 | 524.00 Mn |
| Apr 30, 2024 | 533.00 Mn |
| Jan 31, 2024 | 522.00 Mn |
| Oct 31, 2023 | 505.00 Mn |
| Jul 31, 2023 | 512.00 Mn |
| Apr 30, 2023 | 519.00 Mn |
| Jan 31, 2023 | 521.00 Mn |
| Oct 31, 2022 | 461.00 Mn |
| Jul 31, 2022 | 498.00 Mn |
| Apr 30, 2022 | 511.00 Mn |
| Jan 31, 2022 | 493.00 Mn |
| Oct 31, 2021 | 441.00 Mn |
| Jul 31, 2021 | 443.00 Mn |